Ketogenic Diet Contraindications and Safety

Ketogenic diet therapy is a medical treatment, not simply a high-fat lifestyle diet. Before it is started for epilepsy, clinicians need to exclude metabolic disorders in which reliance on fat metabolism could be dangerous.

Why screening comes first

Classical ketogenic diet therapy shifts much of the body’s energy supply from carbohydrate toward fat and ketone metabolism.

If a person cannot safely transport or oxidise fatty acids, the diet can precipitate severe metabolic decompensation.

Important absolute contraindications

Recognised contraindications include disorders affecting fatty-acid transport or oxidation and certain other metabolic pathways.

Examples include:

primary carnitine deficiency;
carnitine palmitoyltransferase I or II deficiency;
carnitine translocase deficiency;
medium-chain, long-chain or other clinically significant fatty-acid oxidation defects;
pyruvate carboxylase deficiency;
porphyria.

Exact screening protocols vary with age, clinical presentation and diet programme.

Why these disorders are dangerous with ketogenic therapy

When carbohydrate availability falls, the body needs to mobilise and oxidise fat.

Someone with a major fatty-acid oxidation defect may be unable to generate sufficient energy and can develop hypoglycaemia, acidosis, liver dysfunction, rhabdomyolysis or other life-threatening complications.

Relative contraindications and situations requiring caution

A 2026 review highlighted conditions in which ketogenic therapy may require additional caution rather than being automatically prohibited.

These can include severe liver or kidney disease, pancreatitis, gallbladder disease, significant dyslipidaemia, cardiac arrhythmia, marked underweight, electrolyte disturbance and particular drug combinations.

Pregnancy

Evidence for ketogenic diet therapy during pregnancy remains limited.

ILAE’s Dietary Therapies Task Force has highlighted the lack of robust pregnancy and lactation data and the need for specialist supervision rather than assuming either safety or harm.

Baseline assessment

Before treatment, programmes commonly assess growth or body weight, nutritional intake, blood count, electrolytes, liver and kidney function, glucose, lipids and relevant metabolic tests.

Children may need more extensive metabolic screening when an underlying disorder is suspected.

Common early adverse effects

Early effects can include:

nausea;
vomiting;
constipation;
abdominal discomfort;
dehydration;
hypoglycaemia;
acidosis;
lethargy during adaptation.

Longer-term risks

Possible longer-term complications include kidney stones, dyslipidaemia, micronutrient deficiency, reduced bone health, poor growth in children, gastrointestinal symptoms and altered menstrual function.

Kidney stones

Ketogenic therapy increases kidney-stone risk.

Hydration and, in some programmes, citrate supplementation are used to reduce risk in appropriate patients.

Bone health

Long-term treatment can affect bone mineral health through several mechanisms, including chronic acidosis, nutrition, limited mobility and antiseizure medicines.

Monitoring is particularly important in children and others already at high fracture risk.

Micronutrient supplementation

Classical ketogenic diets restrict several food groups.

Vitamin and mineral supplementation is therefore usually required, guided by the specialist dietetic team.

Carnitine

Carnitine is not automatically supplemented in every patient.

Levels, symptoms and concurrent medicines can influence whether supplementation is appropriate.

Valproate

Valproate and ketogenic therapy can be used together, but both can affect metabolism and liver function.

Clinical monitoring is important, particularly if lethargy, vomiting, hypoglycaemia or liver dysfunction develops.

Propofol

Prolonged or high-dose propofol exposure is a recognised concern during ketogenic therapy because of the risk of propofol infusion syndrome and impaired fatty-acid metabolism.

Anaesthetic teams should know when a patient is receiving ketogenic therapy.

SGLT2 inhibitors and diabetes medicines

Some glucose-lowering medicines can increase the risk of ketoacidosis or hypoglycaemia when combined with severe carbohydrate restriction.

People with diabetes require specialist metabolic oversight.

Illness and fasting

Vomiting, poor intake and acute illness can disturb hydration, glucose and acid–base balance.

Every ketogenic diet programme should provide a sick-day plan.

Do not start the diet unsupervised

Online ketogenic diets designed for weight loss are not equivalent to epilepsy ketogenic therapy.

Therapeutic programmes require neurologic and dietetic supervision, appropriate formulation and laboratory monitoring.

The central point

The ketogenic diet can be highly effective for selected epilepsies, but its safety depends on screening, medical supervision and ongoing nutritional and biochemical monitoring.

Sources

Evidence checked: September 2026.